FDA and VACCINE

HEALTH AND SCIENCE

FDA says Pfizer Covid vaccine provides some protection after first dose, meets success criteria

PUBLISHED TUE, DEC 8 20208:04 AM ESTUPDATED TUE, DEC 8 202010:08 AM EST

 

Berkeley Lovelace Jr.@BERKELEYJR

 

 

 

 

KEY POINTS

• The FDA said data from Pfizer’s coronavirus vaccine trials was “consistent” with recommendations put forth by the agency for an emergency use authorization.
• FDA staff also said data submitted appeared to show the vaccine provided protection after the first dose.
• It added that two doses of the vaccine were “highly effective” in preventing confirmed cases of Covid-19.